TickerFactsScreenerDevelopers

Summit Therapeutics Inc. (SMMT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$35.11M2020: -$48.11M2021: -$72.59M2022: -$41.58M2023: -$76.76M2024: -$142.11M2025: -$322.93M-$322.93M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$322.93M-127.2%
2024-$142.11M-85.1%
2023-$76.76M-84.6%
2022-$41.58M+42.7%
2021-$72.59M-50.9%
2020-$48.11M-37.0%
2019-$35.11M—